Abstract
Hepatosplenic T-cell lymphoma is a very difficult lymphoma to deal with, almost impossible to cure. “Tandem” consolidation therapy with auto-stem cell transplant and allo-stem cell transplant can induce a long-lasting response and potentially cure this disease.
References
1.
Yabe
M
, Miranda
RN
, Medeiros
LJ
. Hepatosplenic T-cell Lymphoma: a review of clinicopathologic features, pathogenesis, and prognostic factors
. Hum Pathol
. 2018 Apr
;74
:5
–16
. .2.
Pro
B
, Allen
P
, Behdad
A
. Hepatosplenic T-cell lymphoma: a rare but challenging entity
. Blood
. 2020 Oct 29
;136
(18
):2018
–26
. .3.
Przybylski
GK
, Wu
H
, Macon
WR
, Finan
J
, Leonard
DG
, Felgar
RE
, Hepatosplenic and subcutaneous panniculitis-like gamma/delta T cell lymphomas are derived from different Vdelta subsets of gamma/delta T lymphocytes
. J Mol Diagn
. 2000 Feb
;2
(1
):11
–9
.4.
Rashidi
A
, Cashen
AF
. Outcomes of allogeneic stem cell transplantation in hepatosplenic T-cell lymphoma
. Blood Cancer J
. 2015 Jun 5
;5
(6
):e318
. .5.
Belhadj
K
, Reyes
F
, Farcet
JP
, Tilly
H
, Bastard
C
, Angonin
R
, Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients
. Blood
. 2003 Dec 15
;102
(13
):4261
–9
.6.
Vose
J
, Armitage
J
, Weisenburger
D
; International T-Cell Lymphoma Project
. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes
. J Clin Oncol
. 2008 Sep 1
;26
(25
):4124
–30
. .7.
Falchook
GS
, Vega
F
, Dang
NH
, Samaniego
F
, Rodriguez
MA
, Champlin
RE
, Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment
. Ann Oncol
. 2009 Jun
;20
(6
):1080
–5
.© 2022 S. Karger AG, Basel
2022
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.